MENU
PTIX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Protagenic Therapeutics (PTIX) Ownership - Who owns Protagenic Therapeutics?

Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders... Show more

Profile

Industry
N/A
Address
149 Fifth Avenue
Phone
+1 212 994-8200
Employees
3
Web
https://www.protagenic.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
3.21M
P/E Ratio
N/A
Total Cash
872.96K
Projected Growth
N/A
Total Debt
419.76K
Revenue
N/A
Risk (Beta)
1.57
Dividend Yield
N/A
Total Cash/Share
1.01
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

PTIX
Capitalization
3.21M
P/E Ratio
N/A
Risk (Beta)
1.57
Dividend Yield
N/A
Total Cash
873K
Total Cash/Share
1.01
Total Debt
420K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
-88.33K
P/B Ratio
1.61
Cash Flow
N/A
Earnings
-13.13
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
54
Current Ratio
0.86
Current Revenue Per Employee
300634.16
Dividends Per Share - Security
N/A
EBITDA
-5.18M
Float
N/A
Float - Current
N/A
Gross Income Margin
-5.50
Revenue To Assets
-293.85
Shares Held By Institutions
63.2K
Shares Outstanding - Current
868K
Total Liabilities
1.08M
Total Volume MTD
N/A
Value
1
Gain YTD
-46.064
View a ticker or compare two or three
PTIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
149 Fifth Avenue
Phone
+1 212 994-8200
Employees
3
Web
https://www.protagenic.com